Center for Scientific Review; Notice of Closed Meetings, 23282-23283 [2018-10589]
Download as PDF
<![CDATA[
23282
Federal Register / Vol. 83, No. 97 / Friday, May 18, 2018 / Notices
clearance. For U.S. citizens, please
RSVP no later than Monday, June 25,
2018. Written comments are welcome
and encouraged, even if you are
planning to attend in person. Please
send them to the email address:
us.who.irhp@hhs.gov.
Dated: May 9, 2018.
G. Garrett Grigsby,
Director for Global Affairs.
[FR Doc. 2018–10634 Filed 5–17–18; 8:45 am]
BILLING CODE 4150–38–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Findings of Research Misconduct
Office of the Secretary, HHS.
ACTION: Notice.
AGENCY:
Findings of research
misconduct have been made on the part
of Maria Cristina Miron Elqutub,
Research Interviewer, University of
Texas MD Anderson Cancer Center
(MDACC). Dr. Elqutub engaged in
research misconduct in research
supported by National Institute of
Dental and Craniofacial Research
(NIDCR), National Institutes of Health
(NIH), grant U01 DE019765–01. The
administrative actions, including three
(3) years of supervision, were
implemented beginning on April 26,
2018, and are detailed below.
FOR FURTHER INFORMATION CONTACT:
Wanda K. Jones, Dr.P.H., Interim
Director, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8200.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the Office of Research
Integrity (ORI) has taken final action in
the following case:
Maria Cristina Miron Elqutub,
University of Texas MD Anderson
Cancer Center: Based on Respondent’s
admission, the report of an inquiry
conducted by MDACC, and analysis
conducted by ORI in its oversight
review, ORI found that Ms. Maria
Cristina Miron Elqutub, Research
Interviewer, MDACC, engaged in
research misconduct in research
supported by NIDCR, NIH, grant U01
DE019765–01.
ORI found that Respondent engaged
in research misconduct by intentionally
and knowingly falsifying and/or
fabricating data that were included in
the following two (2) published papers
and two (2) grant progress reports
submitted to NIDCR, NIH:
• PLoS One 10(6):e0128753, 2015 Jun
2 (hereafter referred to as ‘‘PLoS One
2015’’).
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:38 May 17, 2018
Jkt 244001
• Cancer 121(14):2367–74, 2015 Jul
15 (hereafter referred to as ‘‘Cancer
2015’’) Retracted in: Cancer 124(4):869,
2018 Feb 15.
• 5 U01 DE019765–04.
• 5 U01 DE019765–05.
Specifically, ORI found that
Respondent engaged in research
misconduct by recording dates and
providing her own blood samples to
cause these samples to be falsely labeled
as samples from ninety-eight (98) study
subjects in a cancer genetics study
involving human blood samples. This
resulted in the reporting of false data in
Tables 1, 2, 3, and 4 in PLoS One 2015,
in Figure 1 and Tables 1, 2, 3, and 4 in
Cancer 2015, and in the Results sections
of Project 2 progress reports for NIDCR,
NIH, grants 5 U01 DE019765–04 and 5
U01 DE019765–05.
Ms. Elqutub entered into a Voluntary
Settlement Agreement and voluntarily
agreed, beginning on April 26, 2018:
(1) To have her research supervised
for a period of three (3) years;
Respondent agreed to ensure that prior
to the submission of an application for
U.S. Public Health Service (PHS)
support for a research project on which
Respondent’s participation is proposed
and prior to Respondent’s participation
in any capacity on PHS-supported
research, the institution employing her
must submit a plan for supervision of
Respondent’s duties to ORI for approval;
the supervision plan must be designed
to ensure the scientific integrity of
Respondent’s research contribution;
Respondent agreed that she will not
participate in any PHS-supported
research until a supervision plan is
submitted to and approved by ORI;
Respondent agreed to maintain
responsibility for compliance with the
agreed upon supervision plan;
(2) that for a period of three (3) years,
any institution employing her must
submit, in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which
Respondent is involved, a certification
to ORI that the data provided by
Respondent are based on actual
experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract;
(3) if no supervisory plan is provided
to ORI, to provide certification to ORI
on an annual basis for a period of three
(3) years that she has not engaged in,
applied for, or had her name included
on any application, proposal, or other
request for PHS funds without prior
notification to ORI;
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
(4) to exclude herself voluntarily from
serving in any advisory capacity to PHS
including, but not limited to, service on
any PHS advisory committee, board,
and/or peer review committee, or as a
consultant for a period of three (3) years;
and
(5) to the correction or retraction of
PLoS One 10(6):e0128753, 2015 Jun 2.
Wanda K. Jones,
Interim Director, Office of Research Integrity.
[FR Doc. 2018–10592 Filed 5–17–18; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Social Sciences and Population Studies A
Study Section.
Date: June 6, 2018.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave. NW, Washington, DC 20037.
Contact Person: Suzanne Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 435–
1712, ryansj@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Development—1
Study Section.
Date: June 12, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Thomas Beres, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7840, Bethesda, MD 20892, 301–435–
1175, berestm@mail.nih.gov.
E:\FR\FM\18MYN1.SGM
18MYN1
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 97 / Friday, May 18, 2018 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Emphasis Panel: Brain Injury and
Neurovascular Pathologies.
Date: June 13, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Alexei Kondratyev, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Emphasis Panel: Brain Injury and
Neurovascular Pathologies.
Date: June 13, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, Brain Disorders and Clinical
Neuroscience, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246, edwardss@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neural Trauma and Stroke.
Date: June 13, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexei Kondratyev, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Molecular
Neuropharmacology and Signaling Study
Section.
Date: June 14–15, 2018.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel & Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Carole L. Jelsema, Ph.D.,
Chief and Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4176,
MSC 7850, Bethesda, MD 20892, (301) 435–
1248, jelsemac@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Tumor Progression and Metastasis Study
Section.
Date: June 14–15, 2018.
Time: 8:00 a.m. to 5:00 p.m.
VerDate Sep<11>2014
16:38 May 17, 2018
Jkt 244001
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites, DC Convention
Center, 900 10th Street NW, Washington, DC
20001.
Contact Person: Rolf Jakobi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7806, Bethesda, MD 20892, 301–495–
1718, jakobir@mail.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Social Sciences and Population Studies B
Study Section.
Date: June 14–15, 2018.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn, Washington, DC,
Downtown, 1199 Vermont Ave. Washington,
DC 20005.
Contact Person: Kate Fothergill, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3142,
Bethesda, MD 20892, 301–435–2309,
fothergillke@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Musculoskeletal, Oral, Skin, Rheumatology
and Rehab Sciences AREA (R15) Review.
Date: June 15, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Aftab A. Ansari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, 301–237–
9931, ansaria@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Biodata Management and Analysis
Study Section.
Date: June 15, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Wenchi Liang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3150,
MSC 7770, Bethesda, MD 20892, 301–435–
0681, liangw3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurogenesis and Bioengineering.
Date: June 15, 2018.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Mei Qin, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
23283
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–875–2215,
qinmei@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neuroimmunology,
Neuroinflammation, and Brain Tumor.
Date: June 15, 2018.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Center
for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference
Call).
Contact Person: Nataliya Gordiyenko,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5202,
MSC 7846, Bethesda, MD 20892,
301.435.1265, gordiyenkon@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR15–359:
Biomarker Studies for Diagnosing
Alzheimer’s Disease and Predicting
Progression.
Date: June 15, 2018.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Room 5211,
Bethesda, MD 20892, 301–760–8207,
schauweckerpe@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 11, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–10589 Filed 5–17–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Interagency Pain
Research Coordinating Committee
(IPRCC).
The meeting will be open to the
public.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: July 9, 2018.
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 83, Number 97 (Friday, May 18, 2018)]
[Notices]
[Pages 23282-23283]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10589]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Social Sciences and Population Studies A
Study Section.
Date: June 6, 2018.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Melrose Hotel, 2430 Pennsylvania Ave. NW, Washington, DC
20037.
Contact Person: Suzanne Ryan, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, (301) 435-
1712, [email protected].
Name of Committee: Cell Biology Integrated Review Group;
Development--1 Study Section.
Date: June 12, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas Beres, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5148, MSC 7840, Bethesda, MD 20892, 301-435-
1175, [email protected].
[[Page 23283]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special Emphasis Panel: Brain Injury and Neurovascular
Pathologies.
Date: June 13, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alexei Kondratyev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD
20892, 301-435-1785, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special Emphasis Panel: Brain Injury and Neurovascular
Pathologies.
Date: June 13, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Samuel C. Edwards, Ph.D., Chief, Brain Disorders
and Clinical Neuroscience, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846,
Bethesda, MD 20892, (301) 435-1246, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neural Trauma and Stroke.
Date: June 13, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alexei Kondratyev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD
20892, 301-435-1785, [email protected].
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Molecular Neuropharmacology
and Signaling Study Section.
Date: June 14-15, 2018.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA
22314.
Contact Person: Carole L. Jelsema, Ph.D., Chief and Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4176, MSC 7850, Bethesda, MD
20892, (301) 435-1248, [email protected].
Name of Committee: Oncology 1--Basic Translational Integrated
Review Group; Tumor Progression and Metastasis Study Section.
Date: June 14-15, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites, DC Convention Center, 900 10th Street NW,
Washington, DC 20001.
Contact Person: Rolf Jakobi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6187, MSC 7806, Bethesda, MD 20892, 301-495-
1718, [email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Social Sciences and Population Studies B
Study Section.
Date: June 14-15, 2018.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn, Washington, DC, Downtown, 1199 Vermont
Ave. Washington, DC 20005.
Contact Person: Kate Fothergill, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3142, Bethesda, MD 20892, 301-
435-2309, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Musculoskeletal, Oral, Skin, Rheumatology and Rehab Sciences
AREA (R15) Review.
Date: June 15, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aftab A. Ansari, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD
20892, 301-237-9931, [email protected].
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Biodata Management and Analysis Study
Section.
Date: June 15, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015.
Contact Person: Wenchi Liang, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3150, MSC 7770, Bethesda, MD 20892, 301-435-
0681, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurogenesis and Bioengineering.
Date: June 15, 2018.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Mei Qin, MD, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5213, Bethesda, MD 20892, 301-875-2215,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neuroimmunology, Neuroinflammation, and
Brain Tumor.
Date: June 15, 2018.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Bethesda, MD 20817 (Telephone
Conference Call).
Contact Person: Nataliya Gordiyenko, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5202, MSC 7846, Bethesda, MD
20892, 301.435.1265, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR15-359: Biomarker Studies for Diagnosing Alzheimer's
Disease and Predicting Progression.
Date: June 15, 2018.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific
Review Officer, National Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Room 5211, Bethesda, MD 20892, 301-
760-8207, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 11, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-10589 Filed 5-17-18; 8:45 am]
BILLING CODE 4140-01-P
